Related Experiment Video

Updated: Jun 2, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis

Yanqiu Hu1, Jun Xing, Lei Wang

  • 1Reproductive Medicine Center, Subei People's Hospital, Yangzhou University, China.

Clinical & Experimental Metastasis
|May 3, 2011
PubMed

Insights

The novel gene RGS22, found on chromosome 8q22.2, shows potential as a tumor suppressor. Its expression is linked to epithelial cancers and metastasis, suggesting it could be a biomarker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RGS22 is a novel gene located on chromosome 8q22.2, a region frequently altered in tumors.
  • Its specific role in human tumorigenesis remains largely unexplored.

Purpose of the Study:

  • To investigate the potential role of RGS22 in human tumorigenesis.
  • To determine the association of RGS22 expression with cancer metastasis and invasion.

Main Methods:

  • Examined RGS22 expression in various tumor types using tissue arrays and immunohistochemistry.
  • Analyzed RGS22 levels in esophageal cancer cell lines with differing metastatic potentials via Western blot.
  • Investigated the functional impact of RGS22 overexpression on cell migration and invasion in a metastatic cell line.

Main Results:

  • RGS22 expression was detected in multiple tumor types, particularly those of epithelial origin, and correlated with cancer metastasis.
  • RGS22 expression was associated with tumor invasion in cancer cell lines.
  • Overexpression of RGS22 in a highly metastatic esophageal cancer cell line led to decreased cell migration and reduced invasive potential.

Conclusions:

  • RGS22 is overexpressed in low-metastatic epithelial cancers and influences cell migration and invasion.
  • RGS22 may function as a tumor suppressor gene in tumorigenesis.
  • RGS22 presents potential as a diagnostic and prognostic biomarker for metastasis, with possible therapeutic implications for epithelial cancer treatment.

More Related Videos

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...